US Health-Care Policy Makes Deals ‘Incredibly Hard’, Advent Says
Health-care policy in the US poses a challenge for investors, whereas there are areas of opportunity in the sector in Europe, according to John Maldonado, managing partner at Advent.
“You have very idiosyncratic things — executive orders that could create substantive change in Big Pharma,” Maldonado said in an interview with Bloomberg Television at the SuperReturn private capital conference in Berlin. “That does make dealmaking incredibly hard.”